Q2 2025 C Rad AB Earnings Call Transcript
Key Points
- C-Rad AB (FRA:24C) achieved an 11% growth in order intake in constant currencies, driven by strong performance in the Americas and EMEA regions.
- The company secured significant deals in both the US and EMEA, including a strategic multi-site contract in France and a large product order in Texas.
- C-Rad AB has a strong order backlog of SEK735 million, providing a solid foundation for future revenue.
- The company has successfully reduced operating expenses by 10% compared to the previous year, demonstrating improved operational efficiency.
- Service revenue showed solid growth, with order intake for services increasing by 86% in constant currencies compared to the previous year.
- Revenue declined by 13% year-on-year in constant currencies, primarily due to a softer order intake in 2024 and the absence of a SEK20 million boost from China deliveries.
- The EBIT margin for the quarter was 8%, impacted by the weaker top line performance.
- APAC region experienced a 15% decline in order intake and a 34% decline in revenue, affected by strong China deliveries in the previous year.
- Gross profit decreased to SEK70 million from SEK88 million a year ago, reflecting the decline in revenue.
- Cash flow from working capital was negative at SEK8 million, although it showed improvement from the previous year.
Welcome to the C-RAD Q2 2025 report presentation. (Operator Instructions).
Now I will hand the conference over to CEO, Cecilia de Leeuw and CFO, Linda Frolen. Please go ahead.
Welcome to our Q2 presentation, and thank you for joining us today in the middle of the Swedish summer. We have concluded a busy quarter with high activity in all markets with an increased order intake and winning deals despite market uncertainty. And as many of you know, the foundation for our offering is the demand and need for safer cancer treatments with a focus on the patient's quality of life.
And it's also about increasing efficiency in the customers' clinics. And we are on a journey. We are building an even stronger C-RAD, working hard on our financial strengths so that we can access both established and untapped markets globally with our world-leading products and services.
So now let's take a look at the Q2 performance and the key takeaways. Q2 was indeed a busy quarter, and we are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
